Study | Design | Citalopram | Escitalopram | Fluoxetine | Fluvoxamine | Paroxetine | Sertraline | Risk of bias in review |
Braun 202060 | SR MA | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ | Low |
Cheng 202061 | Model based MA | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ | Low |
Furukawa 201923 | SR MA | ↑ | ↔ | ↔ | ↔ | ∩ | Low | |
Furukawa 202063 | SR MA | ↔ | ↔ | ↔ | ↔ | ↔ | Low | |
Dold 201762 | SR MA | ↔ | ↔ | ↔ | Low | |||
Benkert 199664 | Narrative review | ↔ | ↔ | ↔ | ↔ | ↔ | Unclear | |
Safer 201620 | Narrative review | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ | Unclear |
Hamza 202181 | MA | ↑ | ↔ | ↔ | ↑ | ↑ | Unclear | |
Vaswani 200370 | Narrative review | ↑ | ↔ | ↔ | ↔ | ↔ | Unclear | |
Tan 199958 | Narrative review | ? | Unclear | |||||
Purgato 201569 | SR, MR | ↔ | Unclear | |||||
Dunner 199256 | Pooled | ↔ | Unclear | |||||
Klemp 201167 | SR, MR | ↔ | Unclear | |||||
Montgomery 199557 | Narrative review | ↔ | Unclear | |||||
Preskorn 199568 | Narrative review | ↔ | Unclear | |||||
Adli 200513 | Narrative review | ↔ | ↔ | ↑ | ↔ | ↔ | High | |
Berney 200573 | Narrative review | ↔ | ↔ | ↔ | ? | ↔ | ↔ | High |
Holper 202087 | Network MA | ↔ | ↑ | ↑ | ↔ | High | ||
Lane 199577 | Narrative review | ↔ | ↔ | ↔ | ↔ | High | ||
Montgomery 199478 | MA | ↔ | High | |||||
Montgomery 199559 | Narrative review | ↔ | High | |||||
Caley 200286 | Narrative review | ↑ | ↔ | ∩ | ? | ↔ | High | |
Lam 200676 | MA | ↔ | High | |||||
Altamura 198871 | Narrative review | ↔ | High | |||||
Beasley 199072 | Pooled | ↔ | High | |||||
Rifkin 199779 | Narrative review | ↔ | ↔ | ↔ | High | |||
Ruhe 200680 | SR, narrative review | ↔ | ↔ | ↔ | High | |||
Jenner 199275 | Pooled | ↔ | High | |||||
Hieronymus 201618 | MA | ↑ | ↑ | ↑ | High | |||
Barbui 200282 | SR MA | ↑ | High | |||||
Parker 200085 | Narrative review | ↑ | High | |||||
Baker 200322 | SR MA | ? | ? | ? | High |
Reviews in this table are are ranked by assessed risk of bias (low to high), most common finding for efficacy, and dose-response effect; selective serotonin reuptake inhibitors ordered alphabetically. MA=meta-analysis; MR=meta-regression; SR=systematic review
*Drug response effects are indicated as ↑ (increased), ↔ (flat), ∩ (curvy linear), or ? (unclear).